Daylight photodynamic therapy for actinic keratoses: a randomized double‐blinded nonsponsored prospective study comparing 5‐aminolaevulinic acid nanoemulsion ( <scp>BF</scp> ‐200) with methyl‐5‐aminolaevulinateNoora Neittaanmäki, Erna Snellman, Toni Karppinen et al.|British Journal of Dermatology|2014Cited by 76
Detecting field cancerization using a hyperspectral imaging systemNoora Neittaanmäki, Erna Snellman, M Grönroos et al.|Lasers in Surgery and Medicine|2013Cited by 43
Hexyl aminolevulinate, 5‐aminolevulinic acid nanoemulsion and methyl aminolevulinate in photodynamic therapy of non‐aggressive basal cell carcinomas: A non‐sponsored, randomized, prospective and double‐blinded trialMari Salmivuori, Noora Neittaanmäki, M Grönroos et al.|Journal of the European Academy of Dermatology and Venereology|2020Cited by 25
Hexyl-5-aminolaevulinate 0·2% vs. methyl-5-aminolaevulinate 16% daylight photodynamic therapy for treatment of actinic keratoses: results of a randomized double-blinded pilot trialNoora Neittaanmäki, Erna Snellman, M Grönroos et al.|British Journal of Dermatology|2015Cited by 18
Long-term Outcome of Daylight Photodynamic Therapy with Amino-5-laevulinate Nanoemulsion vs. Methyl-5-aminolaevulinate for Actinic KeratosesNoora Neittaanmäki, Erna Snellman, M Grönroos et al.|Acta Dermato Venereologica|2016Cited by 11